Transmission of hepatitis C virus: rates, routes, and cofactors.
about
What's in a virus? Folk understandings of hepatitis C infection and infectiousness among injecting drug users in Kings Cross, SydneyThe impact of changes to heroin supply on blood-borne virus notifications and injecting related harms in New South Wales, Australia.Prevalence of Hepatitis C Among Australian Aboriginal and Torres Strait Islander people: A Systematic Review and Meta-AnalysisPrevention of hepatitis C virus in injecting drug users: a narrow window of opportunityPrevalence of hepatitis C among injection drug users in England and Wales: is harm reduction working?An overview of triple infection with hepatitis B, C and D viruses.A national survey of genitourinary medicine clinic attenders provides little evidence of sexual transmission of hepatitis C virus infection.Assessment of long-term outcomes of hepatitis C virus infection in a cohort of patients with acute hepatitis in 1971-1975: results of a pilot study.A case-control study of risk factors for sporadic hepatitis C virus infection in the southwestern United States.Seroprevalence and clinical characteristics of viral hepatitis in transfusion-dependent thalassemia and hemophilia patients.Hepatitis C infection in children: a Melbourne perspective.A case-control study of risk factors for hepatitis C infection in patients with unexplained routes of infection.Prevalence and risk factors for hepatitis C virus infection among young Thai men.Route of administration for illicit prescription opioids: a comparison of rural and urban drug users.Prevalence of hepatitis C antibodies in a large sample of Belgian healthcare workers.Hepatitis C in a ward for cystic fibrosis and diabetic patients: possible transmission by spring-loaded finger-stick devices for self-monitoring of capillary blood glucose.Hepatitis C among drug users: consensus guidelines on management in general practice.Hepatitis C and pregnancy: an update.Blood-borne viruses and their survival in the environment: is public concern about community needlestick exposures justified?Developing and validating a scoring tool for identifying people who inject drugs at increased risk of hepatitis C virus infection.Prevalence and correlates of HCV, HVB, and HIV infection among prison inmates and staff, HungaryPrevalence of HIV and hepatitis C virus infections among inmates of Quebec provincial prisons.How can hepatitis C be prevented in the long term?Trends in hepatitis B virus, hepatitis C virus, and human immunodeficiency virus prevalence, risk behaviors, and preventive measures among Seattle injection drug users aged 18-30 years, 1994-2004.Alternate Routes of Administration among Prescription Opioid Misusers and Associations with Sexual HIV Transmission Risk BehaviorsThe social production of hepatitis C risk among injecting drug users: a qualitative synthesis.Hepatitis C and G Virus Infection Prevalence Among Hemodialysis Patients and Associated Risk Factors in the Hormozgan Province of Southern IranMorbidity and mortality profile of human immunodeficiency virus-infected patients with and without hepatitis C co-infection.Elimination of hepatitis C virus infection among people who inject drugs through treatment as prevention: feasibility and future requirements.Contrasting patterns of hepatitis C virus infection in two regions from Tunisia.Decline in incidence of HIV and hepatitis C virus infection among injecting drug users in Amsterdam; evidence for harm reduction?Modelling the impact on Hepatitis C transmission of reducing syringe sharing: London case study.Incidence and risk factors for hepatitis C seroconversion in injecting drug users in Australia.Estimating population attributable risk for hepatitis C seroconversion in injecting drug users in Australia: implications for prevention policy and planning.Changes in risk behavior and dynamics of hepatitis C virus infections among young drug users in Amsterdam, the Netherlands.The injection of methadone syrup in New South Wales: patterns of use and increased harm after partial banning of injecting equipment.Remarkable difference in the mode of HCV transmission among haemodialysis patients and IVDAs.HIV and hepatitis C among injecting drug users.Measuring the incidence, prevalence and genetic relatedness of hepatitis C infections among a community recruited sample of injecting drug users, using dried blood spots.Hepatitis C virus: laboratory surveillance in England and Wales, 1992-2004.
P2860
Q24795489-B29D08BC-C95E-433B-8B51-50E663321205Q24811537-A46B4DCC-5559-4362-A1A5-8DC0FC1913C1Q28077377-EF62009E-B390-4B4B-85EB-B533F88E127DQ28741305-73767C0D-C94A-4636-9B1C-76A3453E7520Q28768135-D84538B5-AF9D-45B8-8122-0C4F009ECD38Q30485092-435E73BF-CAFB-4E99-91E3-DF155632C032Q31152033-FEE76EB9-11BC-4148-BC10-CA8AFB68C679Q33590872-16D9A609-12CC-4BB2-AC73-3276BFEAE2A4Q33611636-6EE1F1A1-F671-4621-ADB8-D812CCEA5DA8Q33783711-CCA9C285-3F36-4344-8AC6-9E6FDBD84045Q33913514-5EC4F698-0779-4AC2-9808-5430300963AAQ34000363-3989F96A-FBB4-4643-9301-0AD6D132FD07Q34024930-67D06AE4-F890-461F-B588-9C92AEFFB882Q34258184-9301907E-4A26-4BCA-8681-5F440158739AQ34507853-4646CED5-6A40-4F6A-B19F-6CF1062172F2Q34529139-89946D70-7526-463E-A612-6718E32E4B25Q34554815-84176F57-3F0F-46C5-A0E9-7E92CCC84820Q35625112-329971F6-2000-4BBD-86AB-DC429A9E1B9BQ35628991-262C47AF-DCF8-434B-B18A-B74F346919B0Q35659866-01EBF414-885B-48D3-81BF-FBF7B37E30DCQ35772275-6CEBD879-5651-44B6-B694-FFFE85163215Q35908638-2CED27ED-51C9-4EC9-A5D0-DB5033D3244DQ36226863-F1709B3C-2EDA-4CFB-9125-3080A173938CQ36440948-F6413F2E-9C78-410F-B136-DC659329D8ADQ37184992-675A025D-655A-4394-884E-4A0FDB1CFA8BQ37281094-CFEF247A-0496-4831-86A1-5ED2DA8B480EQ37417388-AB232AAD-13DD-4A57-BA28-5283BD794BE9Q37609379-CCB24363-84FD-4EED-BB46-E441FE170BB7Q38407675-075B61AB-6A63-41F3-A088-1915E6F086A4Q39242327-AC6E3806-C2BD-48E7-9A34-17242218DC8FQ39479623-765A0948-CBB9-4C11-8E2C-636B82044F1CQ39559479-AD6561C0-A0F2-457E-85A8-301DE652C6DEQ39768496-E28E37D5-3625-4428-81FF-F178DB75A498Q39902810-F80064D8-DAE0-46F9-A1ED-A8C9341D7558Q40377223-EB4EF4BB-D37E-40DF-BE02-0DEFF9032301Q42614566-4F52E627-6D9F-4242-A2B7-56BE67138184Q42719527-756D1AC0-3623-49F7-BEB8-751212CC50C8Q42757973-22C5C77C-B68B-4F07-8FAE-8E0FFC23EA75Q42996974-EAE38E45-CD2E-4FAF-8D56-353BAE78C9EFQ43031120-90AAE2C3-3EDE-4564-B52D-4550A81D3781
P2860
Transmission of hepatitis C virus: rates, routes, and cofactors.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Transmission of hepatitis C virus: rates, routes, and cofactors.
@en
type
label
Transmission of hepatitis C virus: rates, routes, and cofactors.
@en
prefLabel
Transmission of hepatitis C virus: rates, routes, and cofactors.
@en
P2093
P1476
Transmission of hepatitis C virus: rates, routes, and cofactors.
@en
P2093
P304
P356
10.1093/OXFORDJOURNALS.EPIREV.A017921
P577
1996-01-01T00:00:00Z